Global Industries Market Research Analysis Reports

A recent report published by The Business Research Company on Antibody Drug Conjugates Market provides in-depth analysis of segments and sub-segments in the global as well as regional. The global antibody drug conjugates market was valued at about $1.89 billion in 2018 and is expected to grow to $4.98 billion at a CAGR of 27.4% through 2022. The antibody-drug conjugates (ADCs) market consists of sales of antibody-drug conjugates (ADCs). Antibody-drug conjugates (ADCs) are complex engineered therapeutics consisting of monoclonal antibodies, directed toward tumor-associated antigens, to which highly potent cytotoxic agents are attached using chemical linkers. View complete Report: https://www.thebusinessresearchcompany.com/report/antibody-drug-conjugates-global-market-report Major players in the market are Bayer AG, Concortis Biotherapeutics, F. Hoffman-La Roche Ltd., Immunomedics, Inc., Oxford BioTherapeutics North America was the largest region in the antibod...